Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In elderly, immune disregulation or immunosenecence have great impact to infection response. This study is aimed to determine the effect of alfacalcidol supplementation in vitro and in vivo to respiratory infection incidence and inflammatory markers, as well as T cell lymphocyte subset in Indonesian elderly patients.
This study consist of 2 designs. First is in vitro study to investigate the effect of alfacalcidol supplementation to IL-6, IL-10 and IFN gamma regulation in Peripheral Blood Mononuclear Cells (PBMC) of elderly and second design is randomised controlled trial to evaluate the effect of 3 months supplementation of alfacalcidol 0,5 mcg in respiratory infection, antibiotic use, inflammatory markers, CD4/CD8 ratio and CD8+ CD28+ in Indonesian elderly with various level of frailty syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
110
alfacalcidol 0,5 mcg
Cipto Mangunkusumo National Hospital
Jakarta, Indonesia
RECRUITINGupper respiratory tract infection incidence
incidence of URTI
Time frame: 90 days
lower respiratory tract infection incidence
incidence of LRTI
Time frame: 90 days
inflammatory markers
IL6, IL10 and IFN gamma in PBMC
Time frame: day 90
T cell subset
CD4/CD8 ratio, CD8+ CD28- percentage
Time frame: day 90
antibiotic use
any antibiotic prescribed by physician
Time frame: 90 days
Aulia Rizka, MD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.